Literature DB >> 18802932

Variability of body weight, pulse pressure and glycaemia strongly predict total mortality in elderly type 2 diabetic patients. The Verona Diabetes Study.

Giacomo Zoppini1, Giuseppe Verlato, Giovanni Targher, Enzo Bonora, Maddalena Trombetta, Michele Muggeo.   

Abstract

BACKGROUND: Ageing is characterized by a decreased functional reserve, a concept defined as homeostenosis. We assessed the impact of long-term exposure to the average value (mean) or to the variability (coefficient of variation) of fasting glycaemia, body mass index (BMI) and pulse pressure on total mortality in a cohort of type 2 diabetic patients.
METHODS: Fasting glycaemia, BMI and pulse pressure values were collected over a period of 3 years in 1 319 type 2 diabetic patients who were subsequently followed up for 10 years. For each patient, the means and the coefficients of variation of fasting glycaemia, BMI and pulse pressure were computed. The adverse impact of these risk factors on total mortality was assessed in patients aged < 65 years (n = 565) and in those aged > or = 65 years (n = 754), separately.
RESULTS: During the 10 years of follow-up, 438 patients died. In younger diabetic patients, the means of fasting glycaemia [hazard ratio (HR) of III tertile versus I tertile = 2.11, 95% confidence interval (CI): 1.22-3.64], BMI (HR = 1.88, 1.12-3.14) and pulse pressure (HR = 2.36, 1.34-4.16) were independently associated with total mortality, while in older patients they were not. In contrast, the coefficients of variation of glycaemia (HR = 1.56, 1.17-2.08), BMI (HR = 1.34, 1.03-1.75) and pulse pressure (HR = 1.34, 1.03-1.74) independently predicted total mortality only in older patients.
CONCLUSIONS: Our findings suggest that the variability of fasting glycaemia, body weight and blood pressure (BP) is independently associated with an increased risk of all-cause mortality in older type 2 diabetic patients. Future studies are required to confirm the reproducibility of our findings. Copyright 2008 John Wiley & Sons, Ltd.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18802932     DOI: 10.1002/dmrr.897

Source DB:  PubMed          Journal:  Diabetes Metab Res Rev        ISSN: 1520-7552            Impact factor:   4.876


  24 in total

Review 1.  Visit-to-visit variability of blood pressure and cardiovascular disease and all-cause mortality: a systematic review and meta-analysis.

Authors:  Keith M Diaz; Rikki M Tanner; Louise Falzon; Emily B Levitan; Kristi Reynolds; Daichi Shimbo; Paul Muntner
Journal:  Hypertension       Date:  2014-07-28       Impact factor: 10.190

2.  Identifying the independent effect of HbA1c variability on adverse health outcomes in patients with Type 2 diabetes.

Authors:  J C Prentice; S D Pizer; P R Conlin
Journal:  Diabet Med       Date:  2016-07-17       Impact factor: 4.359

3.  Body-Mass Index and All-Cause Mortality in US Adults With and Without Diabetes.

Authors:  Chandra L Jackson; Hsin-Chieh Yeh; Moyses Szklo; Frank B Hu; Nae-Yuh Wang; Rosemary Dray-Spira; Frederick L Brancati
Journal:  J Gen Intern Med       Date:  2013-08-09       Impact factor: 5.128

4.  Admission Glucose Number (AGN): A Point of Admission Score Associated With Inpatient Glucose Variability, Hypoglycemia, and Mortality.

Authors:  Jennifer McKechnie; Rahat Maitland; Christopher A R Sainsbury; Gregory C Jones
Journal:  J Diabetes Sci Technol       Date:  2018-09-24

Review 5.  Variability of risk factors and diabetes complications.

Authors:  Antonio Ceriello; Francesco Prattichizzo
Journal:  Cardiovasc Diabetol       Date:  2021-05-07       Impact factor: 9.951

6.  Ethnic differences in glycaemic control in people with type 2 diabetes mellitus living in Scotland.

Authors:  Preeti H Negandhi; Nazim Ghouri; Helen M Colhoun; Colin M Fischbacher; Robert S Lindsay; John A McKnight; John Petrie; Sam Philip; Naveed Sattar; Sarah H Wild
Journal:  PLoS One       Date:  2013-12-16       Impact factor: 3.240

7.  Visit-to-visit variability of fasting plasma glucose as predictor of ischemic stroke: competing risk analysis in a national cohort of Taiwan Diabetes Study.

Authors:  Cheng-Chieh Lin; Chun-Pai Yang; Chia-Ing Li; Chiu-Shong Liu; Ching-Chu Chen; Wen-Yuan Lin; Kai-Lin Hwang; Sing-Yu Yang; Tsai-Chung Li
Journal:  BMC Med       Date:  2014-09-26       Impact factor: 8.775

8.  Increased Hemoglobin A1c Time in Range Reduces Adverse Health Outcomes in Older Adults With Diabetes.

Authors:  Julia C Prentice; David C Mohr; Libin Zhang; Donglin Li; Aaron Legler; Richard E Nelson; Paul R Conlin
Journal:  Diabetes Care       Date:  2021-06-14       Impact factor: 17.152

9.  The effects of glucose fluctuation on the severity of coronary artery disease in type 2 diabetes mellitus.

Authors:  Xingguang Zhang; Xiuping Xu; Xiumin Jiao; Jinxiao Wu; Shujing Zhou; Xiaofeng Lv
Journal:  J Diabetes Res       Date:  2013-07-07       Impact factor: 4.011

10.  Patterns of weight change after the diagnosis of type 2 diabetes in Scotland and their relationship with glycaemic control, mortality and cardiovascular outcomes: a retrospective cohort study.

Authors:  Lorna S Aucott; Sam Philip; Alison Avenell; Ebenezer Afolabi; Naveed Sattar; Sarah Wild
Journal:  BMJ Open       Date:  2016-07-26       Impact factor: 2.692

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.